Follow
Xin Yiqiao
Xin Yiqiao
Analysis Group, Inc. Previous: University of Glasgow
Verified email at glasgow.ac.uk
Title
Cited by
Cited by
Year
MetaInsight: an interactive web‐based tool for analyzing, interrogating, and visualizing network meta‐analyses using R‐shiny and netmeta
RK Owen, N Bradbury, Y Xin, N Cooper, A Sutton
Research synthesis methods 10 (4), 569-581, 2019
1712019
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network …
Y Takaoka, T Suzuki, D Yoneoka, Y Nishikawa, WW San Tam, J Morze, ...
Cochrane Database of Systematic Reviews, 2021
692021
Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic
TJ Quinn, JK Burton, B Carter, N Cooper, K Dwan, R Field, SC Freeman, ...
BMC medicine 19, 1-10, 2021
522021
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis
Y Xin, J Manson, L Govan, R Harbour, J Bennison, E Watson, O Wu
BMC gastroenterology 16, 1-18, 2016
452016
Cost-effectiveness of HBV and HCV screening strategies–a systematic review of existing modelling techniques
C Geue, O Wu, Y Xin, R Heggie, S Hutchinson, NK Martin, E Fenwick, ...
PloS one 10 (12), e0145022, 2015
452015
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management …
Y Xin, A Davies, A Briggs, L McCombie, CM Messow, E Grieve, WS Leslie, ...
Diabetologia 63, 2112-2122, 2020
322020
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes
Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ...
The lancet Diabetes & endocrinology 7 (3), 169-172, 2019
322019
Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis
L Govan, O Wu, Y Xin, SJ Hutchinson, N Hawkins
European journal of gastroenterology & hepatology 27 (8), 882-894, 2015
272015
Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial
Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ...
Diabetic Medicine 36 (8), 1003-1012, 2019
252019
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review
CKH Wong, Q Liao, VYW Guo, Y Xin, CLK Lam
Vaccine 35 (24), 3153-3161, 2017
242017
Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: results from a cluster randomised controlled trial
RF Hunter, JM Murray, A Gough, J Tang, CC Patterson, DP French, ...
international journal of behavioral nutrition and physical activity 15, 1-13, 2018
232018
Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson’s: a systematic review
Y Xin, E McIntosh
Quality of Life Research 26, 1-23, 2017
172017
Cost-effectiveness of the PDSAFE personalised physiotherapy intervention for fall prevention in Parkinson’s: an economic evaluation alongside a randomised controlled trial
Y Xin, A Ashburn, RM Pickering, KC Seymour, S Hulbert, C Fitton, ...
BMC neurology 20, 1-9, 2020
92020
Isolation, characterization and biological activity of a novel peptide from sika (Cervus nippon Temminck) antler
FJ Huang, JX Ji, J Qian, KY Yang, Y Zhang, YQ Xin, ZG Jing, MH Wang, ...
Pharmaceutical Biotechnology 2, 012, 2010
82010
A loyalty scheme to encourage physical activity in office workers: a cluster RCT
R Hunter, A Gough, J Murray, J Tang, S Brennan, O Chrzanowski-Smith, ...
Public Health Research 7 (15), 1-144, 2019
62019
Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: a cluster randomised controlled trial
RF Hunter, JM Murray, A Gough, J Tang, C Patterson, DP French, ...
The Lancet 392, S4, 2018
52018
From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R
Y Xin, E Gray, JA Robles-Zurita, H Haghpanahan, R Heggie, ...
Applied health economics and health policy, 1-10, 2022
42022
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
X Lu, ZY Zhou, Y Xin, MJ Wang, E Gray, V Jairath, JO Lindsay
Inflammatory Bowel Diseases 30 (1), 64-77, 2024
32024
Feasibility study for interactive reporting of network meta-analysis: experiences from the development of the MetaInsight COVID-19 app for stakeholder exploration, re-analysis …
Y Xin, CR Nevill, J Nevill, E Gray, NJ Cooper, N Bradbury, AJ Sutton
BMC Medical Research Methodology 22 (1), 26, 2022
32022
Forget polypharmacy for type 2 diabetes! Weight management is a better investment
M Lean, L McCombie, Y Xin
Nephrology Dialysis Transplantation 37 (5), 844-846, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20